Long Ideas - Australian-listed Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) gave updates today on the company’s ongoing Phase II trials for lead compound PBT2, a potential treatment for neurodegenerative diseases Alzheimer’s … Continue Reading
Read nowLong Ideas - Shares of PROLOR Biotech (NYSEAMEX:PBTH) are trading up this morning after Jefferies initiated a “Buy” rating with an $8 price target. The company develops a … Continue Reading
Read nowLong Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) announced after the close yesterday that its newly issued patent (U.S. Patent No. 8,242,131, or the ‘131 patent) was posted in the … Continue Reading
Read nowShort Ideas - Alexza Pharmaceuticals (NASDAQ:ALXA) reported this morning that the company’s Adasuve manufacturing facility in Mountain View, CA received a Certificate of GMP (Good Manufacturing Practice) Compliance … Continue Reading
Read nowLong Ideas - Pfizer (NYSE:PFE) announced this morning that the FDA delayed a decision on its rheumatoid arthritis treatment Tofacitinib by at least three months. The agency was … Continue Reading
Read nowLong Ideas - Medtronic (NYSE:MDT) reported fiscal 1Q 2013 EPS of $0.85, in-line with expectations, with revenues also largely meeting forecasts ($4.01 billion vs. consensus estimate of $4.0 … Continue Reading
Read nowQuick Picks - Shares of Amarin Corp. (NASDAQ:AMRN) are up about 2% this morning against a weak tape, as Jeffries analyst Thomas Wei commented that the delay in … Continue Reading
Read now